Related Experiment Video
Updated: Jun 22, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea
Chung Hyun Tae1, Sung-Ae Jung, Hyun Joo Song
1Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
Abstract:
Clostridium difficile (C. difficile) is a common causative agent of pseudomembranous colitis (PMC). C. difficile-associated diarrhea (CDAD) ranges from mild diarrhea to life threatening PMC. Recently, a highly virulent strain of C. difficile polymerase chain reaction ribotype 027 was found in North America, Europe, and Japan. A 52-yr-old woman with anti-tuberculosis medication and neurogenic bladder due to traffic accident experienced five episodes of C. difficile PMC after taking antibiotics for pneumonia along with septic shock and acute renal failure. She was readmitted to the intensive care unit and treated with oral vancomycin with refractory of oral metronidazole, inotropics and probiotics for over 60 days. C. difficile isolated both at the first and the last admission was identified as C. difficile ribotype 027 by ribotyping, toxinotyping, and tcdC gene sequencing, which turned out the same pathogen as the epidemic hypervirulent B1/NAP1 strain. This is the first case of C. difficile PCR ribotype 027 in Korea. After discharge, she was maintained on probiotics and rifaximin for 3 weeks. She had no relapse for 6 months.
Insights
This case report details the first identification of the hypervirulent Clostridium difficile (C. difficile) PCR ribotype 027 strain in Korea. The patient experienced recurrent, severe C. difficile-associated diarrhea and pseudomembranous colitis.
Area of Science:
- Infectious Diseases
- Microbiology
- Gastroenterology
Background:
- Clostridium difficile (C. difficile) is a significant cause of antibiotic-associated diarrhea and colitis.
- A hypervirulent strain, C. difficile polymerase chain reaction (PCR) ribotype 027, has emerged globally.
- This strain is associated with more severe disease and higher mortality rates.
Observation:
- A 52-year-old woman with underlying conditions presented with recurrent C. difficile-associated diarrhea (CDAD) and pseudomembranous colitis (PMC).
- She experienced multiple episodes refractory to standard treatments, including oral metronidazole.
- The causative pathogen was identified as C. difficile PCR ribotype 027, a strain previously un reported in Korea.
Findings:
- Genetic analysis confirmed the isolated C. difficile strain as PCR ribotype 027, matching the epidemic hypervirulent B1/NAP1 strain.
- The patient required prolonged intensive care unit management and treatment with oral vancomycin, inotropics, and probiotics.
- Successful management was achieved with probiotics and rifaximin post-discharge, with no relapse for six months.
Implications:
- This case marks the first documented occurrence of the C. difficile PCR ribotype 027 strain in Korea.
- Highlights the importance of recognizing and managing infections caused by hypervirulent C. difficile strains.
- Suggests potential therapeutic strategies involving probiotics and rifaximin for refractory cases.
Related Concept Videos
Bacterial Gastroenteritis
Clinical Significance of Antibiotic Resistance
Investigation of Disease Outbreaks
Microbiota Modulation by Antibiotics

